Aequus Pharmaceuticals Inc.

    Aequus Pharmaceuticals Inc.

    TTSXV:AQS
    0.01
    CAD
    0.00
    (0.00%)
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    TTM
    Revenue per Share
    - -
    - -
    - -
    0.01
    0.02
    0.02
    0.02
    0.03
    0.02
    0.01
    - -
    - -
    0.01
    Basic EPS, GAAP
    -0.08
    -0.1
    -0.15
    -0.1
    -0.06
    -0.04
    -0.04
    -0.01
    -0.01
    -0.02
    -0.02
    -0.02
    - -
    Free Cash Flow per Basic Share
    -0.04
    -0.05
    -0.12
    -0.1
    -0.06
    -0.03
    -0.02
    -0.01
    -0.01
    -0.01
    -0.02
    -0.01
    - -
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -0.08
    -0.16
    -0.26
    -0.29
    -0.01
    -0.02
    -0.06
    -0.04
    -0.02
    -0.04
    -0.07
    -0.08
    -0.09
    Tangible Book Value per Share
    0.01
    0.12
    0.02
    - -
    0.02
    0.01
    -0.01
    0.01
    0.01
    -0.01
    -0.03
    -0.05
    -0.05
    Basic Weighted Avg Shares
    21
    25
    34
    47
    68
    76
    80
    93
    129
    133
    133
    133
    133
    Sales/Revenue/Turnover
    - -
    - -
    - -
    1
    1
    1
    2
    3
    3
    1
    - -
    1
    1
    Operating Margin (%)
    - -
    - -
    - -
    -693.18
    -343.38
    -199.12
    -135.86
    -20.29
    -50.37
    -181.05
    -1,106.45
    -364.1
    -62.5
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Net Income, GAAP
    -2
    -2
    -5
    -5
    -4
    -3
    -3
    -1
    -2
    -3
    -3
    -2
    -1
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    - -
    -685.84
    -340.74
    -198.81
    -190.26
    -40.32
    -66.66
    -232.65
    -1,163.11
    -372.74
    -71.46
    Working Capital
    - -
    3
    - -
    - -
    1
    1
    1
    2
    1
    -1
    -4
    -7
    -7
    LT Debt
    - -
    - -
    - -
    - -
    - -
    - -
    2
    2
    - -
    1
    1
    - -
    - -
    Total Equity
    - -
    3
    1
    1
    2
    2
    -1
    1
    2
    -1
    -4
    -6
    -7
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    4.2
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Mar'25
    Jun'25
    Sep'25
    ST Debt
    6
    6
    6
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    133
    133
    133
    Market Capitalization
    1
    1
    - -

    Working Capital

    CAD

    •

    in mil. unless spec.
    Mar'25
    Jun'25
    Sep'25
    Total Current Assets
    - -
    - -
    - -
    Cash, Cash Equivalents & STI
    - -
    - -
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    7
    7
    7
    Payables & Accruals
    1
    1
    1
    ST Debt
    6
    6
    6
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -2.4%
    26.12%
    50.33%
    Free Cash Flow
    17.8%
    9.94%
    -27.81%
    Net Income, GAAP
    11.75%
    9.99%
    -26.55%
    Sales/Revenue/Turnover
    - -
    12.41%
    129.21%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    1
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.01
    -0.01
    -0.01
    - -
    -0.02
    2024
    - -
    -0.01
    - -
    - -
    -0.02
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business